Backed by a robust history in venture capital, the fund manager brings extensive experience in technology and healthcare sectors across North America and Europe. With a portfolio that includes over 30 successful deals, they have demonstrated a strong track record in early-stage investments. Notable exits have included leading firms in the SaaS and biopharma spaces, showcasing their strategic, operator-first approach to investment. Their data-driven insights have consistently identified high-growth opportunities, positioning them as a key player in the competitive landscape.